2026-22235NoticeWallet

Cincinnati Pharma Plant Gets the Green Light for Trade Benefits

Published Date: 10/30/2026

Notice

Summary

Patheon API, Inc. in Cincinnati got the green light to start making pharmaceutical products in their Foreign-Trade Zone facility. This means they can produce medicines with special trade benefits, helping them save money and speed up operations. The approval was finalized on October 27, 2026, so they can get to work right away!

Analyzed Economic Effects

1 provisions identified: 1 benefits, 0 costs, 0 mixed.

FTZ Authorization for Pharmaceutical Production

Patheon API, Inc. in Cincinnati is authorized to produce pharmaceutical products inside Foreign-Trade Zone 46 (Subzone 46K). The company submitted its notification on March 9, 2026, a Federal Register notice ran on March 13, 2026, and the authorization was finalized on October 27, 2026. The document states the activity is authorized under FTZ rules, allowing the firm to use Foreign-Trade Zone trade provisions that can help reduce costs and speed operations.

Personalized for You

How does this regulation affect your finances?

Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Key Dates

Effective Date
Published Date
10/27/2026
10/30/2026

Department and Agencies

Department
Independent Agency
Agency
Commerce Department
Foreign-Trade Zones Board
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register